Vivos Therapeutics
VVOS
VVOS
29 hedge funds and large institutions have $5.02M invested in Vivos Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
45% less capital invested
Capital invested by funds: $9.14M → $5.02M (-$4.12M)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
29
Holding in Top 10
–
Calls
$278K
Puts
$260K
Top Buyers
| 1 | +$579K | |
| 2 | +$275K | |
| 3 | +$138K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.4K |
Top Sellers
| 1 | -$699K | |
| 2 | -$143K | |
| 3 | -$143K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$139K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$120K |